A Preemptive Prescription to Cyber Exposure Management
Organizations need to take a proactive approach to identify, prioritize and mitigate threats in real…
A Preemptive Prescription to Cyber Exposure Management
Organizations need to take a proactive approach to identify, prioritize and mitigate threats in real time. This means gaining visibility and control into all physical and virtual assets. The post A Preemptive Prescription to Cyber Exposure Management appeared first on MedCity News.
Improving Patient Payment Collections: Strategies for Success
By reimagining the payment experience through transparency, flexibility, and technology, providers can drive better outcomes for both their bottom line and the patients they serve. The post Improving Patient Payment Collections: Strategies for Success appeared first on MedCity News.
Investors Share How Early Stage Healthcare Startups Are Using AI
[Sponsored] Business banking provider* Mercury sponsored a webinar discussing early stage investment topics with venture capitalists such as grant funding secrets, capital valuation, the role of AI in life sciences, and more. The post Investors Share How Early Stage Healthcare Startups Are Using AI appeared first on MedCity News.
As Federal Health Grants Shrink, Memory Cafes Help Dementia Patients and Their Caregivers
Rob Kennedy mingled with about a dozen other people in a community space in Clarks Summit, Pennsylvania. The room, decorated with an under-the-sea theme, had a balloon arch decked out with streamers meant to look like jellyfish and a cloud of clear balloons mimicking ocean bubbles. Kennedy comes to this memory cafe twice a month…
What AI and Grief-bots Can Teach Us About Supporting Grieving People
By MELISSA LUNARDI The Rise of Digital Grief Support We’re witnessing a shift in how we process one of humanity’s most universal experiences: grief. Several companies have emerged in recent years to develop grief-related technology, where users can interact with AI versions of deceased loved ones or turn to general AI platforms for grief support….
Merck RSV Drug for Infants Wins FDA Nod, But CDC Committee That Will Advise on Its Use is Gutted
FDA approval of Merck’s RSV antibody drug, Enflonsia, makes it a direct competitor to Sanofi’s Beyfortus. The new Merck product is expected to be discussed by the CDC’s Advisory Committee on Immunization Practices; ACIP will have an entirely new roster at its next meeting after all 17 sitting members were dismissed by Health and Human…
GoodRx Unveils Cost-Plus Model for Independent Pharmacies
GoodRx launched Community Link, a new cost-plus pricing program that allows independent pharmacies to contract directly with GoodRx. The post GoodRx Unveils Cost-Plus Model for Independent Pharmacies appeared first on MedCity News.
In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say
The Trump administration has cancelled $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses. In addition, since President Donald Trump took office, at least half of the security council’s staff have been laid off or left. This is dangerous say former health security officials. The post In Axing mRNA Contract, Trump…
Whole Eye Transplantation is No Longer Just Science Fiction
The technologies and techniques developed for eye transplantation and nerve regeneration may have significant translational potential for other biomedical needs including: spinal cord injury, central nervous system regeneration, retinal cell and tissue transplantation, and other forms of organ and tissue transplantation. The post Whole Eye Transplantation is No Longer Just Science Fiction appeared first on…
Metsera’s Amylin Drug Looks Good in Phase 1, Shows Potential to be a Once-Monthly Obesity Med
Novo Nordisk, AbbVie, and Roche each have weekly injectable drug candidates designed to bind to and activate the amylin receptor to trigger weight loss. Metsera’s contender, MET-233i, is designed with technology that enables longer dosing intervals and the company is proceeding with development of this engineered peptide as a monotherapy and as part of a…
